On April 23, 2021, the President signed four bills into law. The first one, S. 164, known as the "Advancing Education on Biosimilars Act of 2021," grants authorization to the Food and Drug Administration (FDA) to educate consumers and healthcare providers on biologic products, including biosimilars. The second bill, S. 415, clarifies the definition of a new chemical entity for FDA approval applications. The third bill, S. 422, called the "Senate Shared Employee Act," permits Senators, Senators-elect, Senate committees, leadership offices, and other Senate offices to share employees. Lastly, S. 578, known as the "Food Allergy Safety, Treatment, Education, and Research Act of 2021" or the FASTER Act of 2021, adds sesame to the list of major allergens for the purpose of food labeling.